African Americans are known to be at an increased risk of angioedema due to an increased sensitivity to bradykinin and polymorphisms in the genes encoding neutral endopeptidase (NEP) and aminopeptidase P (APP) [22,23]. The gene discussed is APP; the disease is angioedema.